// App-Quantinova.ai

5187 : PET imaging of trastuzumab emtansine (T-DM1) drug delivery to intracranial patient derived xenograft (PDX) models of breast cancer metastasis

Researchers

Presenter

  • Carsten Haagen Nielsen

Principal Investigators

  • Mette K. Nedergaard

  • Lotte K. Kristensen

  • Camilla S. Knudsen

  • Michael J. Wick

  • Kyri Papadopoulos

  • Anthony Tolcher

  • Andreas Kjaer

Medical Centers

  • Minerva Imaging, Copenhagen, Denmark

  • START-South Texas Accelerated Research Therapeutics, LLC, San Antonio, TX

  • Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Denmark.

Locations

  • United States

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Brain metastasis

  • Solid malignancies

Biomarkers

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • Trastuzumab emtansine

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final